PMV Pharmaceuticals Inc.

PMVP | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.49

+$0.01 (+1.02%)

Sep 22, 2026, 9:44 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $78.66M

Enterprise Value $-549.65K

Beta 1.37

Average Volume 410.14K

Shares Outstanding (Diluted) 53.39M

Shares Change YoY 2.65%

Institutional Ownership 69.31%

Exchange NASDAQ

ISIN US69353Y1038

Price Performance

Price Change 1M 11.3%

Price Change 3M 22.3%

Price Change 6M 8.0%

Price Change YTD 20.3%

Price Change 1Y 10.4%

Price Change 3Y -76.8%

Price Change 5Y -94.9%

1M CAGR (ann.) 24.4%

1Y CAGR (ann.) 20.3%

5Y CAGR (ann.) -44.6%

All-Time CAGR -41.7%

Valuation

PE Ratio -1.04

Forward PE N/A

PEG Ratio -0.11

Forward PEG 0.04

PS Ratio N/A

Forward PS 12.70

PB Ratio 1.10

P/FCF Ratio -1.10

P/Adj. FCF Ratio -1.02

P/OCF Ratio -1.11

EV/Sales N/A

EV/EBIT 0.01

EV/EBITDA 0.01

EV/FCF 0.01

Earnings Yield -96.0%

FCF Yield -90.6%

Adj. FCF Yield -97.8%

Financial Health

Net Cash $79.21M

Total Debt $217K

Cash & Short-Term Investments $79.43M

Total Assets $82.07M

Current Ratio 7.70

Quick Ratio 7.70

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt -328.41

Interest Coverage 0.00

Altman Z-Score -5.79

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -8.0%

Returns

Return on Assets -91.7%

Return on Equity -78.1%

Return on Invested Capital -111.1%

Return on Capital Employed -111.4%

Return on Tangible Assets -91.7%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -17.1%

EPS CAGR 5Y 1.9%

EPS CAGR 10Y N/A

FCF CAGR 3Y -19.9%

FCF CAGR 5Y -4.1%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 4

EPS Growth Next 3Y 20.7%

Revenue Growth Next 3Y N/A

Earnings Date Nov 10, 2026

EPS Estimate (next Q) -$0.31

EPS Growth Est (next Q) -22.5%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $5

Price Target Upside 237.8%

Cash Flow

Operating Cash Flow $-71.27M

Free Cash Flow $-71.28M

Adj. Free Cash Flow $-76.96M

FCF Per Share -$1.34

OCF Per Share -$1.33

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-34K

Operating Income $-79.66M

EBITDA $-75.91M

Net Income $-75.22M

EPS (Diluted) -$1.42

Revenue / Employee N/A

Profit / Employee $-1.39M

Employees 54